GE Healthcare
Sophia Genetics Q3 Revenues Increase 44 Percent
Net loss for the bioinformatics firm, which went public in July, more than doubled year over year during the third quarter to $10.2 million.
Sophia Genetics Files for $100M IPO, Inks Cancer Data Deal With GE Healthcare
Sophia, which will trade on the Nasdaq, seeks to raise $100 million in an IPO, and separately announced a partnership with GE Healthcare.
Seeing Opportunity in Digital Diagnostics, Roche Agreements Seek to Expand IVD Business Model
Premium
Roche Diagnostics CEO said that it seeks to continue generating cash from its current IVD businesses, in part to fund investments in digital diagnostics.
Inspirata Buys Caradigm From GE Healthcare
Inspirata plans to leverage Caradigm's software to accelerate the development of Inspirata's cancer big data platform called Cancer Information Data Trust.
ArcticZymes said last week that it has inked a supply agreement with GE Healthcare Life Sciences for products based on ArcticZymes' portfolio of heat-labile enzymes.